Literature DB >> 16448676

Increased ethanol consumption and preference and decreased ethanol sensitivity in female FAAH knockout mice.

Balapal S Basavarajappa1, Ratnakumar Yalamanchili, Benjamin F Cravatt, Thomas B Cooper, Basalingappa L Hungund.   

Abstract

Previous studies have shown that mice lacking cannabinoid (CB1) receptor gene consume markedly reduced levels of ethanol. Mice lacking the enzyme fatty acid amidohydrolase (FAAH) are severely impaired in their ability to degrade anandamide (AEA) and therefore represent a unique animal model in which to examine the function of AEA in vivo on ethanol-drinking behavior. In the current study, FAAH(-/-) mice were tested for ethanol, saccharin or quinine consumption and preference. Ethanol-induced hypothermia, and sleep time were used to evaluate the sensitivity to acute effects of ethanol. Ethanol intake and preference were increased only in female FAAH(-/-) mice. No significant difference in saccharin or quinine consumption or preference was observed between genotypes. Female FAAH(-/-) mice were less sensitive to the hypothermic and sedative/hypnotic effects of acute ethanol. Supersensitivity to exogenous AEA was noted in both male and female FAAH(-/-) mice. Following voluntary ethanol consumption, CB1 receptor levels and function were down-regulated in male FAAH(+/+), FAAH(-/-), and female FAAH(+/+) mice but not in female FAAH(-/-) mice. Our results suggest that absence of an effect in male mice indicates a sex-linked mechanism that is secondary (or modulatory) to FAAH function. Thus, the data suggest that FAAH may be indirectly related to ethanol intake and sensitivity and central endocannabinoidergic-mediated pathways may regulate ethanol consumption.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16448676     DOI: 10.1016/j.neuropharm.2005.12.005

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  50 in total

Review 1.  Sex differences in cannabinoid pharmacology: a reflection of differences in the endocannabinoid system?

Authors:  Rebecca M Craft; Julie A Marusich; Jenny L Wiley
Journal:  Life Sci       Date:  2012-06-20       Impact factor: 5.037

2.  Acute ethanol suppresses glutamatergic neurotransmission through endocannabinoids in hippocampal neurons.

Authors:  Balapal S Basavarajappa; Ipe Ninan; Ottavio Arancio
Journal:  J Neurochem       Date:  2008-09-15       Impact factor: 5.372

Review 3.  Genes and Alcohol Consumption: Studies with Mutant Mice.

Authors:  J Mayfield; M A Arends; R A Harris; Y A Blednov
Journal:  Int Rev Neurobiol       Date:  2016       Impact factor: 3.230

4.  Innate difference in the endocannabinoid signaling and its modulation by alcohol consumption in alcohol-preferring sP rats.

Authors:  K Yaragudri Vinod; Paola Maccioni; Maria Salud Garcia-Gutierrez; Teresa Femenia; Shan Xie; Mauro A M Carai; Jorge Manzanares; Thomas B Cooper; Basalingappa L Hungund; Giancarlo Colombo
Journal:  Addict Biol       Date:  2011-02-11       Impact factor: 4.280

Review 5.  Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors.

Authors:  Antonia Serrano; Loren H Parsons
Journal:  Pharmacol Ther       Date:  2011-07-18       Impact factor: 12.310

6.  Blockade of alcohol escalation and "relapse" drinking by pharmacological FAAH inhibition in male and female C57BL/6J mice.

Authors:  Yan Zhou; Benjamin I Schwartz; Joanna Giza; Steven S Gross; Francis S Lee; Mary Jeanne Kreek
Journal:  Psychopharmacology (Berl)       Date:  2017-07-20       Impact factor: 4.530

7.  Chronic ethanol exposure increases voluntary home cage intake in adult male, but not female, Long-Evans rats.

Authors:  Melissa Morales; Molly M McGinnis; Brian A McCool
Journal:  Pharmacol Biochem Behav       Date:  2015-10-26       Impact factor: 3.533

8.  Biochanin A, a naturally occurring inhibitor of fatty acid amide hydrolase.

Authors:  L Thors; J J Burston; B J Alter; M K McKinney; B F Cravatt; R A Ross; R G Pertwee; R W Gereau; J L Wiley; C J Fowler
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

9.  D3 dopamine receptors and a missense mutation of fatty acid amide hydrolase linked in mouse and men: implication for addiction.

Authors:  Esmaeil Mansouri; José N Nobrega; Matthew N Hill; Rachel F Tyndale; Francis S Lee; Christian S Hendershot; Laura M Best; Patricia Di Ciano; Georgia Balsevich; Mathew E Sloan; Stephen J Kish; Junchao Tong; Bernard Le Foll; Isabelle Boileau
Journal:  Neuropsychopharmacology       Date:  2019-11-27       Impact factor: 7.853

Review 10.  Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders.

Authors:  Ewa Galaj; Zheng-Xiong Xi
Journal:  CNS Drugs       Date:  2019-10       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.